Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review

被引:0
作者
Tawhari, Ibrahim [1 ,2 ,3 ]
Saggese, Samantha [2 ]
Alshahrani, Shatha S. [1 ]
Asiri, Ghufran [1 ]
Alshahrani, Shatha A. [1 ]
Summan, Sarah [1 ]
Al Qasim, Yousef Y. [1 ]
Al Majbar, Yahya A. [1 ]
机构
[1] King Khalid Univ, Abha, Saudi Arabia
[2] Northwestern Univ Feinberg Sch Med, Chicago, IL USA
[3] King Khalid Univ, Dept Internal Med, Abha 61421, Saudi Arabia
来源
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS | 2024年 / 12卷
关键词
A xylosoxidans; peritonitis; peritoneal dialysis; Achromobacter xylosoxidans infection; tunnel infection; RESISTANCE; PATTERNS;
D O I
10.1177/23247096231220467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Achromobacter xylosoxidans is a gram-negative bacterium that is responsible for rare peritonitis associated with peritoneal dialysis (PD). We present a case of a 64-year-old woman with a medical history of end-stage renal disease undergoing PD who was admitted to the emergency department with abdominal pain and nausea. Physical examination and laboratory studies revealed peritoneal signs and laboratory abnormalities consistent with peritonitis. Intraperitoneal catheter dysfunction was identified and subsequently resolved via laparoscopy. Following a peritoneal fluid culture, A xylosoxidans was identified, leading to the initiation of intraperitoneal meropenem treatment. After an initial improvement, the patient developed an ileus and recurrent abdominal symptoms, and further peritoneal cultures remained positive for A xylosoxidans. Subsequent treatment included intravenous meropenem and vancomycin for Clostridium difficile colitis. Owing to the high likelihood of biofilm formation on the PD catheter by A xylosoxidans, the catheter was removed, and the patient transitioned to hemodialysis. Intravenous meropenem was continued for 2 weeks post-catheter removal. This case highlights the challenges in managing recurrent peritonitis in PD patients caused by multidrug-resistant A xylosoxidans. A high index of suspicion, appropriate microbiological identification, and targeted intraperitoneal and systemic antibiotic treatment, along with catheter management, are crucial in achieving a favorable outcome in such cases.
引用
收藏
页数:5
相关论文
共 25 条
  • [11] 전지민, 2011, Kidney Research and Clinical Practice, V30, P215
  • [12] Kim Hyun Jin, 2018, Electrolyte Blood Press, V16, P27, DOI 10.5049/EBP.2018.16.2.27
  • [13] Kishore K., 2019, J Clin Nephrol, V3, P66, DOI [10.29328/journal.jcn.1001028, DOI 10.29328/JOURNAL.JCN.1001028]
  • [14] Continuous Ambulatory Peritoneal Dialysis-Related Peritonitis in an Uremic Outpatient: Achromobacter xylosoxidans
    Kocak, Gulay
    Azak, Alper
    Huddam, Bulent
    Yanik, Sinan
    Duranay, Murat
    [J]. BLOOD PURIFICATION, 2012, 34 (01) : 1 - 2
  • [15] A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient
    Lebeaux, David
    Merabishvili, Maia
    Caudron, Eric
    Lannoy, Damien
    Van Simaey, Leen
    Duyvejonck, Hans
    Guillemain, Romain
    Thumerelle, Caroline
    Podglajen, Isabelle
    Compain, Fabrice
    Kassis, Najiby
    Mainardi, Jean-Luc
    Wittmann, Johannes
    Rohde, Christine
    Pirnay, Jean-Paul
    Dufour, Nicolas
    Vermeulen, Stefan
    Gansemans, Yannick
    Van Nieuwerburgh, Filip
    Vaneechoutte, Mario
    [J]. VIRUSES-BASEL, 2021, 13 (01):
  • [16] Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans
    Magallon, Arnaud
    Amoureux, Lucie
    Garrigos, Thomas
    Sonois, Marine
    Varin, Veronique
    Neuwirth, Catherine
    Bador, Julien
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 926 - 929
  • [17] Marcos MC., 2017, J Infect Dis Ther, V05, P335, DOI [10.4172/2332-0877.1000335, DOI 10.4172/2332-0877.1000335]
  • [18] Sepsis Due to Achromobacter xylosoxidans in a Tertiary Care Centre: Case Series
    Mudey, Gargi
    Kunjalwar, Radha
    Sahu, Gaurav
    Mahajan, Shital M.
    Meshram, Supriya
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [19] 0 Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of Achromobacter xylosoxidans
    Nielsen, Signe M.
    Penstoft, Line N.
    Norskov-Lauritsen, Niels
    [J]. PATHOGENS, 2019, 8 (01)
  • [20] Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans : A Case Report and Comprehensive Literature Review
    Oh, Tak Geun
    Baek, Ji Hyeon
    Jeong, Su Jin
    Chae, Yoon Tae
    Ku, Nam Su
    Chin, Bum Sik
    Han, Sang Hoon
    Kim, Chang Oh
    Song, Young Goo
    Lee, Ho Yong
    Kim, June Myung
    Choi, Jun Yong
    [J]. INFECTION AND CHEMOTHERAPY, 2011, 43 (03) : 275 - 278